662 filings
SC TO-T/A
ALPN
Alpine Immune Sciences Inc
8 May 24
Third party tender offer statement (amended)
8:54am
10-Q
2024 Q1
VRTX
Vertex Pharmaceuticals, Inc.
Quarterly report
7 May 24
4:14pm
8-K
VRTX
Vertex Pharmaceuticals, Inc.
6 May 24
Vertex Reports First Quarter 2024 Financial Results
4:03pm
SC TO-T
ALPN
Alpine Immune Sciences Inc
22 Apr 24
Third party tender offer statement
4:15pm
PX14A6G
Arjuna Capital
16 Apr 24
Letter to shareholders
4:56pm
SC TO-C
0cs75 50q3
11 Apr 24
Information about tender offer
4:08pm
SC TO-C
8ivuzg6
11 Apr 24
Information about tender offer
7:17am
8-K
pjzslq o108p
11 Apr 24
Entry into a Material Definitive Agreement
7:13am
SC TO-C
li7nmra3
10 Apr 24
Information about tender offer
5:22pm
ARS
7sgqhn99iw1q u39ki
4 Apr 24
Annual report to shareholders
4:05pm
DEFA14A
ipbglias
4 Apr 24
Additional proxy soliciting materials
4:03pm
8-K
gilriltz7bk5u7eye4l
5 Feb 24
Vertex Reports Fourth Quarter and Full Year 2023 Financial Results
4:09pm
8-K
1kn42i2
8 Dec 23
Other Events
12:59pm
8-K
ib1z0q3kelik34h
5 Dec 23
Departure of Directors or Certain Officers
4:14pm
8-K
lxh2lqz t872hxi2apf6
6 Nov 23
Vertex Reports Third Quarter 2023 Financial Results
4:05pm
8-K
ctv43o yf
5 Oct 23
Departure of Directors or Certain Officers
4:01pm